OVERVIEW

2025 International Society for Pharmaceutical Engineering (ISPE) Pharma 4.0™ Conference is organized by International Society for Pharmaceutical Engineering (ISPE) and will be held from Dec 09 - 10, 2025 at InterContinental Barcelona, Barcelona, Catalonia, Spain.

Conference Overview:
The 2025 ISPE Pharma 4.0™ Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™. Pharma 4.0 is a holistic end-to-end implementation of digitalization across all stages of project execution, manufacturing, and regulatory processes and along the pharmaceutical supply chain. The key challenges of drug shortages and drug availability can be tackled by the increasing support and impact of innovative enabling technologies, such as artificial intelligence (AI), machine learning (ML), virtual and augmented reality, IIoT, Gxp Cloud & low code platforms, robotics, advanced modeling and automation. Digital transformation is significantly advancing pharmaceutical quality as it builds the foundation for the Quality by Design and process understanding approach to manage the holistic control strategy concept based on an accurate data management and well understood and controlled process models.

More than ever, an emphasis on cross-discipline collaboration is needed to holistically implement and integrate these groundbreaking technologies, while ensuring operational excellence, organizational readiness, and preparing the workforce of the future. This conference seeks to illuminate their profound impact on efficiency, innovation, and operational excellence and even more: its transformational capabilities.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. These sessions showcase recent innovations and trends and directly discuss practical challenges and solutions from a technical, logistical, and regulatory perspective. Our education program offers cutting-edge technical sessions shedding light on the latest advancements in areas like supply chain operations, facilities design and maintenance, and regulatory affairs, with a focus on how Pharma 4.0 is driving the next generation of product development, production systems, and quality assurance.

Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference program.

Featured Topics:
Enabling Effective Digital Transformation in Operations
Content Areas
The 2025 ISPE Pharma 4.0™ Conference International Program Committee are requesting proposals aligning with the following content areas. When formulating proposals the Program Committee desires to see the following approach included in the proposals: key success factors, roadmap for implementation, expected benefits, business case, and challenges:

AI Case Studies: Benefits and Challenges
Artificial Intelligence is no longer a future ambition—it’s a present reality reshaping pharmaceutical operations across critical domains. This track presents four expert-led case studies that illustrate both the tangible benefits and the practical hurdles of applying AI in areas such as quality assurance, manufacturing, laboratory operations, and global investigations. From AI-powered dashboards that transform quality decision-making, to digital twins optimizing lab scheduling and predictive maintenance, and advanced analytics improving yield and compliance in GxP environments—each presentation offers a unique lens into the opportunities and challenges of AI adoption in pharma. Sessions will explore the use of AI-driven techniques to accelerate root cause analysis, cross-functional platforms for quality maturity assessment, predictive maintenance strategies in QC labs, and AI-driven process intelligence in manufacturing. These examples highlight both the technological innovation and the operational realities of integrating AI into regulated environments.

Attendees will gain practical and actionable insights into scaling AI initiatives, overcoming data fragmentation, and embedding digital tools into existing workflows. The track will conclude with reflections on governance, change management, and the human-centered innovation needed to unlock AI’s full potential in Pharma 4.0.

Automation and Advanced Robotics
This track will explore how intelligent automation and robotic technologies are transforming pharmaceutical operations—from manufacturing and warehousing to laboratories and material movement.
Sessions will highlight the benefits of automation, including increased plant capacity, improved productivity, enhanced OEE, reduced downtime, and improved operator safety. Case studies and technical presentations will also address key implementation challenges, such as the impact on facility design, the need to demonstrate business value to justify higher installation costs, and the complexity of integrating automation systems with digital infrastructure.
Topics include the use of robots and collaborative robots (cobots), automated guided vehicles, and advanced material handling solutions in regulated environments in manufacturing as well as labs.

Data-Driven Manufacturing Excellence Solutions
Digital Transformation needs an innovative approach to build holistic data structures enabling data-driven decision support. This track will showcase how pharma organizations managed the shift to data-driven decisions supporting manufacturing processes to enable end-to-end supply resiliency. This will be presented from various perspectives, including operations, quality, engineering, and IT. Topics include strategic planning and preparing for transformational change, selecting the right l-based methodology, and how the quality aspect of digital transformation is driving the digital transformation. The Quality department is changing from only quality control to proactive control. Ultimately, attendees will see how Quality can act not as a barrier, but as a strategic partner driving digital transformation.

Data-Driven Quality Decisions
This track will explore how digital transformation makes real-time quality decisions possible. Real-time data capture in a fully connected environment where data integrity has been ensured can be used for real-time quality control, quality assurance, batch release, process control, and process optimization, among other applications. The track will also cover the establishment of a digital Ongoing Process Verification framework for consistent product quality, process monitoring, and discuss how real-time data capture and advanced visualization tools can transform QA practices.
The track will conclude with a Q&A and panel discussion, providing an opportunity for participants to engage with the experts and gain further insights into real-time quality decisions.

Innovative Facility Design
The world is constantly looking for opportunites for pharmaceutical production capacity increases. More medicines hit the market and quickly became blockbusters. This has led the industry to constantly innovate and expand facilities. This track will showcase some lessons learned from important pharmaceutical companies and vendors, which may be useful for anyone working on or approaching an expansion project. The track will deep dive not only into engineering and technology aspects and new trends, which need to be always taken into account for such projects, but will also focus on the most important company asset: people. Attendees will learn best practices to apply for Design Innovative facilities and for workforce upskilling.

PAT as an Enabler for Digital Transformation
For the first time, we will host a track dedicated to Process Analytical Technology (PAT) and explore how PAT is a true enabler for Digital Transformation. This track will highlight how PAT is revolutionizing the pharmaceutical industry by embedding it into broader digital strategies. You'll learn about the integration of PAT into manufacturing control systems, the vision of plug-and-play for PAT equipment, and the implementation of PAT in continuous API manufacturing. Discover how PAT and digitalization are enhancing mRNA manufacturing processes and how PAT is also used as a strategic element in addressing pharmaceutical supply chain vulnerabilities with innovative, AI-driven, modular API manufacturing. This track promises invaluable insights from industry leaders on how PAT is driving digital transformation and shaping the future of pharmaceutical manufacturing. The track will conclude with a Q&A and panel discussion, providing an opportunity for participants to engage with the PAT experts.

Pharma 4.0™: Preparing for the Future
The future of Pharma 4.0 is here—and it’s smarter, greener, and more connected than ever. This high-energy track dives into how digital transformation is reshaping the industry, from sustainable innovation powered by data to seamless collaboration through open data spaces and federated ecosystems. Discover how large language models are unlocking the value of unstructured data, driving compliance, efficiency, and breakthrough insights. Get the latest from the Pharma 4.0 Community of Practice, including two brand-new, recently published Good Practice Guides—Validation 4.0 and Holistic Digital Enablement—and the launch of a cutting-edge subcommittee focused on Automation and Advanced Robotics. This session offers a forward-looking perspective for professionals ready to lead the next era of pharmaceutical innovation.

Smart Validation (CSV) & QA for Smart Technologies: AI and Beyond
Cloud platforms, AI, and automation are no longer future concepts — they are redefining how systems are built, validated, and operated today. With this shift comes both immense opportunities and new regulatory challenges. This track explores how compliance should be embedded from the outset, turning it into an enabler of digital transformation rather than a barrier.

The session focus on applying GAMP® 5 Second Edition, the GAMP® AI Guide, and the Digital Validation Guide in practice, highlighting data integrity as the foundation for reliable AI and showing how business processes can be translated into risk-based, testable requirements. The track will also address supplier qualification and continuous oversight in cloud and outsourcing environments, and how business continuity and disaster recovery strategies safeguard resilient digital infrastructures.

Authors and core team members of the mentioned GAMP® and ISPE Guides will share first-hand insights and forward-looking perspectives. Digital compliance is not just about meeting regulations — it is a catalyst for innovation, resilience, and lasting transformation.